Study to Determine the Effect of Repeated Administration of Diltiazem on the Pharmacokinetics of Darapladib (Sb-480848).
Clinical trial NCT01852565 · COMPLETED
Trial details
- NCT number
- NCT01852565
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-14
- Primary completion
- 2013-09-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.